Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease - Results of an international survey - On behalf of the subcommittee on von willebrand factor of the scientific and standardization committee of the ISTH

被引：0
|
作者：
Mazurier, C
Meyer, D
机构：
[1] HOP BICETRE,INSERM U143,UNITE RECH HEMOSTASE & THROMBOSE,F-94275 LE KREMLIN BICETR,FRANCE
[2] CRTS,LFB,LAB RECH HEMOSTASE,LILLE,FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1996年 / 76卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 274
页数：5
相关论文
共 50 条
  • [21] Von Willebrand Factor and von Willebrand disease: new approaches to diagnosis
    Ines Woods, Adriana
    Noemi Blanco, Alicia
    Catalina Kempfer, Ana
    Paiva, Juvenal
    Ines Bermejo, Emilse
    Sanchez Luceros, Analia
    Angela Lazzari, Maria
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (02): : 273 - 289
  • [22] Von Willebrand factor and von Willebrand disease - Preface
    Michiels, JJ
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : VII - VII
  • [23] Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
    Allen, S
    Abuzenadah, AM
    Blagg, JL
    Hinks, J
    Nesbitt, IM
    Goodeve, AC
    Gursel, T
    Ingerslev, J
    Peake, IR
    Daly, ME
    BLOOD, 2000, 95 (06) : 2000 - 2007
  • [24] The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis
    Favaloro, E. J.
    Mohammed, S.
    Oliver, S.
    HAEMOPHILIA, 2018, 24 (01) : 20 - 23
  • [25] IMPACT OF ANEMIA ON VON WILLEBRAND FACTOR AND FACTOR VIII IN TYPE 1 VON WILLEBRAND DISEASE AND MILD HEMOPHILIA
    Febres, Maria E. Carter
    Tarango, Cristina
    Fenchel, Matthew
    Pomales, Jennifer
    Mullins, Eric
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E18 - E18
  • [26] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
  • [27] Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2
    Menache, D
    HAEMOPHILIA, 1998, 4 : 44 - 47
  • [28] Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
    Sadler, J. E.
    Budde, U.
    Eikenboom, J. C. J.
    Favaloro, E. J.
    Hill, F. G. H.
    Holmberg, L.
    Ingerslev, J.
    Lee, C. A.
    Lillicrap, D.
    Mannucci, M.
    Mazurier, C.
    Meyer, D.
    Nichols, W. L.
    Nishino, M.
    Peake, I. R.
    Rodeghiero, F.
    Schneppenheim, R.
    Ruggeri, Z. M.
    Srivastava, A.
    Montgomery, R. R.
    Federici, A. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) : 2103 - 2114
  • [29] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [30] VON WILLEBRAND FACTOR INHIBITORS IN TYPE 3 VON WILLEBRAND DISEASE: CHALLENGES IN DIAGNOSIS
    Megdiche, F.
    Kassar, O.
    Krichen, I.
    Kallel, F.
    Ghorbel, M.
    Elloumi, M.
    Kallel, C.
    HAEMOPHILIA, 2020, 26 : 135 - 135
12345